Teal background image.

Governor Hochul Celebrates Unither Pharmaceuticals’ $106 Million Investment to Modernize 350,000 Square-Foot Facility in Monroe County

French-Based Company Commits to 43,000 Square-Foot Expansion in Town of Henrietta to Reduce Carbon Emissions, Expand Warehouse Capabilities, and Improve Sustainability Measures – Will Create Up to 180 New Jobs

Builds on Governor’s Vision of a Modern, 21st Century Economy Fueled by Innovative and Sustainable Businesses

Investment Complements “Finger Lakes Forward” – The Region’s Comprehensive Strategy to Revitalize Communities and Grow the Economy

Governor Kathy Hochul today announced that Unither Pharmaceuticals, a French-based pharmaceutical contract and development manufacturing company, will invest $106 million to consolidate, renovate, and update its facility in the Town of Henrietta, Monroe County as part of an effort to modernize its New York State operations. The significant investment will support a 43,000 square-foot expansion to accommodate new equipment, expand warehouse capabilities, and update the facility’s laboratories in a more energy-efficient building. In addition, Unither will demolish portions of the Jefferson Road facility to improve operational efficiencies, reduce carbon emissions, and implement other energy cost-saving measures. In exchange for a state investment, Unither has committed to creating up to 180 high-quality jobs over the next five years, in addition to 300 employees currently on site.

“Unither’s major investment in Monroe County will help to further establish Upstate New York as not only a leader in next-generation manufacturing, but also as a pioneer in green technology,” Governor Hochul said. “More and more, businesses are looking to New York as the place to grow, create, and innovate, and my administration will continue to work with any business looking to call our state home and help drive our economy into the 21st century.”

Unither Pharmaceuticals CEO Eric Goupil said, “We are extremely pleased to benefit from the support of Empire State Development, Monroe County, RG & E, and Greater Rochester Enterprise in extending our facility while reducing our carbon footprint. Unither’s purpose is to provide innovative, competitive, and easy to use solutions to simplify the life of patients around the world while reducing our Carbon footprint and our impact on the environment and taking care of our employees to offer them job opportunities and careers possibilities. This expansion will enable our Rochester plant to increase its capacity on preservative-free sterile products and will allow us to support our customers in their growth. Thanks to the dynamism of all local stakeholders, we are confident to reach a leadership position in the US.”

Unither Pharmaceuticals, which purchased the Monroe County facility in 2013, produces several lines of medications and medication delivery options including, Preservative-Free Blow-Fill-Seal products for eye drops and inhalation; liquid stick packs for oral solutions and suspensions; bottled cough and cold syrup and capsules with extended release. In addition to its manufacturing capabilities, the company also offers a wide range of services to support pharmaceutical drug development, clinical studies, regulatory support and technical transfer prior to commercialization. Founded 30 years ago and headquartered in Paris, France, Unither maintains manufacturing facilities in the US, France, Brazil and China, employing more than 2,300 people worldwide.

Empire State Development is supporting Unither with its modernization plan with up to $7 million in through the performance-based Excelsior Jobs Tax Credit program. Monroe County, Rochester Gas & Electric and Greater Rochester Enterprise are also assisting with the project.

Empire State Development President, CEO & Commissioner Hope Knight said, “New York State is committed to supporting innovative companies that are dedicated to energy-efficient operations as they build their businesses here. Unither’s climate friendly upgrade of its Henrietta facility reflects the global pharmaceutical leader’s commitment to the Finger Lakes region and its alignment with Governor Hochul’s vision for a sustainable economy that protects the environment while growing New York jobs and opportunity.”

Read the full press release here.